Company Filing History:
1 out of 815 
1 out of 4 
1 out of 6 Years Active: 2014
Title: Innovations by Kazuhiro Irie: Focusing on Alzheimer's Disease
Introduction
Kazuhiro Irie, an innovative inventor based in Kyoto, Japan, has made a significant contribution to the field of Alzheimer's disease research. With a focus on antibody development, Irie has addressed one of the critical challenges in treating this neurodegenerative condition through his patented invention.
Latest Patents
Kazuhiro Irie's sole patent is titled "Antibody recognizing turn structure in amyloid β." This innovative patent provides a therapeutic method that exclusively targets a specific turn structure of the amyloid β protein (Aβ). The patent details an antibody that specifically recognizes an amyloid β having a turn structure at amino acid positions 22 and 23. Furthermore, it describes a medicinal composition that includes this antibody as the active ingredient, aimed at recognizing a toxic conformer of amyloid β. The patent also encompasses an assay kit tailored for detecting this toxic conformer, as well as a diagnostic tool for Alzheimer's disease.
Career Highlights
Throughout his career, Kazuhiro Irie has been affiliated with prestigious institutions that highlight his commitment to advancing medical research. Notably, he has worked at Kyoto University, where much of his research is rooted in the study of neurodegenerative diseases. Additionally, he has contributed to the Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, further emphasizing his dedication to geriatric medicine and research.
Collaborations
During his professional journey, Kazuhiro Irie has collaborated with esteemed colleagues, including Kazuma Murakami and Yuichi Masuda. These partnerships have played a crucial role in bolstering the research efforts aimed at understanding and combating Alzheimer's disease.
Conclusion
Kazuhiro Irie's contributions through his innovative patent demonstrate a significant stride in the development of targeted therapies for Alzheimer's disease. His collaboration with leading research institutions and colleagues underscores the importance of teamwork in addressing complex health challenges. As research continues to evolve, Irie's work will undoubtedly influence future therapeutic strategies in neurosciences.